Post-marketing surveillance of pitavastatin in hypercholesterolaemia: the Livalo Effectiveness and Safety (LIVES) Study extension.

Trial Profile

Post-marketing surveillance of pitavastatin in hypercholesterolaemia: the Livalo Effectiveness and Safety (LIVES) Study extension.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2011

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms LIVES
  • Most Recent Events

    • 09 Nov 2011 Additional lead trial centre identified as reported by University Hospital Medical Information Network - Japan.
    • 14 Sep 2011 Actual initiation date (Oct 2007) added, additional lead trial investigator (Tamio Teramoto) identified, additional location (Japan) identified as reported by University Hospital Medical Information Network - Japan.
    • 14 Sep 2011 New source identified and integrated (University Hospital Medical Information Network - Japan; UMIN000000807).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top